At this time in our medical development, one of the greatest concerns we have as a population and as individuals is what will happen to our memory and cognition, will it persist at a high level? There are no magic bullets, but we are learning new things in the lab that we hope will lead to treatments in the clinic.
The oncoming epidemic of Alzheimer's disease (AD)
is staggering to consider. Currently, an estimated 5 million Americans have Alzheimer's disease, both diagnosed and undiagnosed, with 36 million worldwide. By 2050 that number will rise to 115 worldwide, which means that if you include the average of two caregivers for each person with Alzheimer's, some 500 million people will have AD or care for someone with AD. That's an enormous impact.
This is why I decided to offer a series of discussions about this disease on our UCTV Brain Channel. I am inviting many of our UCSD-affiliated experts on research and treatment to discuss the following aspects of Alzheimer's Disease:
- Clinical diagnosis
- Clinical Trials
- Treatments and therapies
- Future research plans
- Our Alzheimer's Project partnership with Dianne Jacob, chair of the San Diego Board of Supervisors
Please join us over the next few months as our On Our Mind program focuses on Alzheimer's Disease
If you would like us to cover a specific topic related to AD, please let us know via firstname.lastname@example.org
William C. Mobley, MD, PhD
Distinguished Professor and Chair,
Department of Neurosciences
Florence Riford Chair of Alzheimer Disease Research
University of California, San Diego
Watch all the programs in On Our Mind: Alzheimer's Disease.